LXM-10

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLXM-10
Drug Alias NameLXM-10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulatorsMuscarinic acetylcholine receptor M4 modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunitMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPeking University Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking University Health Science Center
Active IndicationsN/A
Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A
Related LinksN/A